Loading...
Portfolio Diversification
Range
Most Diversified
32 instruments
August 19, 2025
Least Diversified
0 instruments
October 26, 2025
Average
29.8 instruments
Most Consistent Holdings
Top 5
BIIB99.23%
REGN99.23%
SRPT99.23%
CRSP99.23%
PFE98.57%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Vertex (VRTX) | 3.63% | 3.21% | 98.57% | - |
 Alnylam (ALNY) | 3.54% | 2% | 98.39% | - |
 Amgen (AMGN) | 3.51% | 3.67% | 98.51% | - |
 Johnson & Johnson (JNJ) | 3.47% | 3.61% | 98.51% | - |
| Regeneron (REGN) | 3.37% | 2.85% | 99.23% | - |
 Bristol-Myers Squibb (BMY) | 3.33% | 3.24% | 98.45% | - |
| CRISPR Therapeutics (CRSP) | 3.31% | 2.78% | 99.23% | - |
| Biogen (BIIB) | 3.17% | 3.26% | 99.23% | - |
| Sarepta (SRPT) | 3.1% | 2.77% | 99.23% | - |
| Pfizer (PFE) | 3.07% | 3.04% | 98.57% | - |
 Gilead Sciences (GILD) | 2.94% | 0% | 84.62% | 1/12/2026 |
 Repligen (RGEN) | 2.91% | 0% | 85.64% | 1/12/2026 |
 Charles River Labs (CRL) | 2.91% | 3.65% | 98.45% | - |
 Jazz Pharmaceuticals (JAZZ) | 2.88% | 0% | 84.98% | 1/12/2026 |
 IQVIA (IQV) | 2.74% | 0% | 84.86% | 1/12/2026 |
 uniQure (QURE) | 2.72% | 5.16% | 78.13% | - |
 AstraZeneca (AZN) | 2.61% | 2.33% | 78.19% | - |
 BeiGene (ONC) | 2.51% | 0% | 64.66% | 1/12/2026 |
 Moderna (MRNA) | 2.45% | 11.92% | 76.04% | - |
 Sanofi (SNY) | 2.21% | 2.51% | 68.06% | - |
 United Therapeutics (UTHR) | 2.18% | 0% | 63.83% | 1/12/2026 |
 GlaxoSmithKline (GSK) | 2.14% | 0% | 63.17% | 1/12/2026 |
 Ascendis Pharma (ASND) | 2.09% | 3.72% | 57.09% | - |
 Bio-Techne (TECH) | 2.09% | 0% | 63.11% | 12/26/2024 |
 Agilent (A.US) | 2.05% | 0% | 61.38% | 1/12/2026 |
 Intellia (NTLA) | 1.97% | 2.29% | 69.55% | - |
 SpringWorks Therapeutics (SWTX) | 1.93% | 0% | 53.4% | 7/3/2025 |
 Blueprint Medicines (BPMC) | 1.9% | 0% | 54.65% | 7/23/2025 |
 Catalent (CTLT) | 1.83% | 0% | 52.21% | 6/26/2024 |
 BioMarin (BMRN) | 1.66% | 3.12% | 57.21% | - |
 Alkermes (ALKS) | 1.43% | 0% | 43.68% | 1/12/2026 |
 Ionis (IONS) | 1.25% | 1.96% | 35.46% | - |
 Novartis (NVS) | 0.96% | 0% | 29.2% | 1/12/2026 |
 Verve Therapeutics (VERV) | 0.88% | 0% | 23.72% | 7/29/2025 |
 Catalyst Pharmaceuticals (CPRX) | 0.69% | 0% | 19.43% | 1/12/2026 |
 Bruker (BRKR) | 0.68% | 0% | 20.26% | 1/9/2023 |
 Revvity (RVTY) | 0.67% | 0% | 20.26% | 1/9/2023 |
 Beam Therapeutics (BEAM) | 0.66% | 2.35% | 21.87% | - |
 Vir (VIR) | 0.6% | 0% | 20.26% | 1/9/2023 |
 Arcturus Therapeutics (ARCT) | 0.57% | 0% | 22.41% | 1/12/2026 |
 BioNTech SE (BNTX) | 0.55% | 0% | 20.26% | 1/9/2023 |
 Syneos Health Inc (SYNH) | 0.54% | 0% | 20.26% | 1/9/2023 |
 Kymera Therapeutics (KYMR) | 0.54% | 4.3% | 13.53% | - |
 Scholar Rock (SRRK) | 0.52% | 3.66% | 13.59% | - |
 Twist Bioscience (TWST) | 0.5% | 0% | 22.17% | 1/12/2026 |
 2Seventy Bio (TSVT) | 0.48% | 0% | 20.26% | 1/9/2023 |
 Fate Therapeutics (FATE) | 0.46% | 0% | 20.92% | 1/9/2023 |
 Exelixis (EXEL) | 0.44% | 0% | 10.91% | 12/26/2024 |
 Bridgebio (BBIO) | 0.44% | 2.78% | 13.53% | - |
 Capricor (CAPR) | 0.42% | 1.06% | 13.17% | - |
 Allogene (ALLO) | 0.37% | 0% | 10.25% | 6/26/2024 |
 Vera (VERA) | 0.36% | 2.1% | 13.41% | - |
 Thermo Fisher (TMO) | 0.36% | 2.7% | 13.17% | - |
 Structure Therapeutics (GPCR) | 0.34% | 1.83% | 13.35% | - |
 Insmed (INSM) | 0.33% | 2.03% | 13.17% | - |
 Caribou Biosciences (CRBU) | 0.32% | 0% | 10.25% | 6/26/2024 |
 Terns (TERN) | 0.29% | 0% | 6.73% | 5/7/2026 |
 Crinetics (CRNX) | 0.28% | 0% | 6.38% | 9/3/2026 |
 Editas (EDIT) | 0.27% | 0% | 10.91% | 6/26/2024 |
 Wave Life Sciences (WVE) | 0.27% | 0.94% | 13.53% | - |
 10X Genomics (TXG) | 0.26% | 0% | 8.7% | 1/12/2026 |
 Travere (TVTX) | 0.22% | 3.53% | 6.5% | - |
 Pacific Biosciences (PACB) | 0.17% | 0% | 10.91% | 6/26/2024 |
 ProQR (PRQR) | 0.16% | 0% | 20.26% | 1/9/2023 |
 Avidity Biosciences (RNA2) | 0.1% | 0% | 3.1% | 3/5/2026 |
 Bayer (BAYN.DE) | 0.04% | 0% | 0.66% | 1/11/2022 |
 Takeda (TAK) | 0.03% | 0% | 0.66% | 1/11/2022 |
 Sangamo (SGMOQ) | 0.02% | 0% | 0.66% | 1/11/2022 |
 Invitae Corp (NVTAQ) | 0.01% | 0% | 0.66% | 1/11/2022 |
 Cellectis SA (CLLS) | 0.01% | 0% | 0.66% | 1/11/2022 |
 Adverum (ADVM) | 0.01% | 0% | 0.66% | 1/11/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Ionis (IONS) | 2.96% | 5.74% |
| BeiGene (ONC) | 3.78% | 4.41% |
| Alnylam (ALNY) | 2% | 4.32% |
| Ascendis Pharma (ASND) | 2.96% | 4% |
| Beam Therapeutics (BEAM) | 2.85% | 3.9% |
| GlaxoSmithKline (GSK) | 2.96% | 3.79% |
| Johnson & Johnson (JNJ) | 3.42% | 3.74% |
| uniQure (QURE) | 1.15% | 3.65% |
| AstraZeneca (AZN) | 3.12% | 3.65% |
| Jazz Pharmaceuticals (JAZZ) | 3.47% | 3.63% |
| United Therapeutics (UTHR) | 2.96% | 3.55% |
| Gilead Sciences (GILD) | 2.27% | 3.45% |
| CRISPR Therapeutics (CRSP) | 4.09% | 3.38% |
| Amgen (AMGN) | 2.66% | 3.27% |
| Biogen (BIIB) | 4.12% | 3.1% |
| 10X Genomics (TXG) | 2.83% | 3.06% |
| IQVIA (IQV) | 3.69% | 2.98% |
| Repligen (RGEN) | 3.79% | 2.94% |
| Vertex (VRTX) | 1.89% | 2.93% |
| Catalyst Pharmaceuticals (CPRX) | 2.83% | 2.87% |
| Agilent (A.US) | 2.83% | 2.87% |
| Regeneron (REGN) | 2.82% | 2.85% |
| Charles River Labs (CRL) | 4.75% | 2.83% |
| Novartis (NVS) | 2.83% | 2.79% |
| Sanofi (SNY) | 2.97% | 2.64% |
| Alkermes (ALKS) | 2.86% | 2.48% |
| Pfizer (PFE) | 4.92% | 2.47% |
| Bristol-Myers Squibb (BMY) | 3.24% | 2.46% |
| BioMarin (BMRN) | 3.95% | 2.35% |
| Twist Bioscience (TWST) | 2.96% | 1.72% |
| Arcturus Therapeutics (ARCT) | 2.96% | 0.98% |
| Sarepta (SRPT) | 2.24% | 0.46% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.